Johns Hopkins and Pitt-linked digital pathology platform Proscia has increased its funding total to $35m with a series B round involving Hitachi Ventures.
Proscia, a US-based digital pathology technology spinout of Johns Hopkins University and University of Pittsburgh, has attracted $23m in a series B round led by Scale Venture Partners.
Hitachi Ventures, the corporate venturing arm of electronics manufacturer Hitachi, took part in the series B round.
Founded in 2014, Proscia has built a modular digital pathology platform that facilitates artificial intelligence-driven image analysis to help diagnose disease based on tissue samples.
The company’s first tool, DermAI, examines skin biopsies to classify variants of dermatological diseases.
Proscia will employ the fresh capital to accelerate its growth plans, bolstering headcount across sales, marketing and customer support, expanding its product portfolio and enhancing its underlying AI and data science.
Proscia has now raised $35m altogether, it said. The spinout raised $1m of seed funding in a 2016 round led by Emerald Development Managers and backed by Robin Hood Ventures, TCP Venture Capital and A-Level Capital.
Proscia then obtained $8.3m of series A capital in a 2018 round led by Flybridge Capital Partners that included Emerald Development, Fusion Fund, Razor’s Edge Ventures and Robin Hood Ventures.
